Alzheimer's disease risk genes and the age-at-onset phenotype

Neurobiol Aging. 2013 Nov;34(11):2696.e1-5. doi: 10.1016/j.neurobiolaging.2013.05.028. Epub 2013 Jul 17.

Abstract

Despite the recent identification of several novel risk genes for Alzheimer's disease (AD), little is known about their influence on the age at onset (AAO) of AD. The AAO is a phenotype with a heritable component distinct from disease risk and may be a useful trait to study in the context of developing interventions for delaying the onset of AD. We studied the influence of 10 recently identified AD risk genes and APOE in relation to AAO in a large cohort of AD patients (N = 2569). We find that the novel AD risk gene, PICALM, exerts a small effect on the AAO of AD with earlier disease onset in risk allele carriers. In addition, we confirmed the previously reported association between the APOE ε4 allele and earlier disease onset. None of the other AD risk genes influenced AAO of AD. Our results suggest that besides APOE, other genes associated with AD risk do not exert large effects on the AAO phenotype of AD.

Keywords: APOE; Age at onset; Alzheimer's disease; Gene; PICALM; Risk.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Cohort Studies
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Monomeric Clathrin Assembly Proteins / genetics*
  • Phenotype*
  • Polymorphism, Genetic / genetics*
  • Risk Factors

Substances

  • Apolipoprotein E4
  • Monomeric Clathrin Assembly Proteins
  • PICALM protein, human